nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—SLCO1A2—epilepsy syndrome	0.147	0.448	CbGaD
Lovastatin—ABCC2—epilepsy syndrome	0.0704	0.214	CbGaD
Lovastatin—CYP2C19—epilepsy syndrome	0.049	0.149	CbGaD
Lovastatin—HDAC2—Valproic Acid—epilepsy syndrome	0.041	0.0898	CbGbCtD
Lovastatin—CYP2D6—epilepsy syndrome	0.0363	0.11	CbGaD
Lovastatin—UGT1A3—Lamotrigine—epilepsy syndrome	0.0304	0.0666	CbGbCtD
Lovastatin—ABCB1—epilepsy syndrome	0.0259	0.0788	CbGaD
Lovastatin—UGT2B7—Carbamazepine—epilepsy syndrome	0.0189	0.0415	CbGbCtD
Lovastatin—ABCC2—Levetiracetam—epilepsy syndrome	0.0173	0.038	CbGbCtD
Lovastatin—UGT1A3—Valproic Acid—epilepsy syndrome	0.0157	0.0343	CbGbCtD
Lovastatin—UGT1A1—Propofol—epilepsy syndrome	0.0137	0.03	CbGbCtD
Lovastatin—UGT2B7—Valproic Acid—epilepsy syndrome	0.0113	0.0248	CbGbCtD
Lovastatin—ABCC2—Carbamazepine—epilepsy syndrome	0.00996	0.0218	CbGbCtD
Lovastatin—ABCC2—Phenytoin—epilepsy syndrome	0.00894	0.0196	CbGbCtD
Lovastatin—ABCC2—Phenobarbital—epilepsy syndrome	0.00796	0.0174	CbGbCtD
Lovastatin—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.00795	0.0174	CbGbCtD
Lovastatin—CYP2C8—Trimethadione—epilepsy syndrome	0.0071	0.0155	CbGbCtD
Lovastatin—CYP2C8—Fosphenytoin—epilepsy syndrome	0.00668	0.0146	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.00665	0.0146	CbGbCtD
Lovastatin—CYP3A7—Carbamazepine—epilepsy syndrome	0.00665	0.0146	CbGbCtD
Lovastatin—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00641	0.014	CbGbCtD
Lovastatin—CYP3A7—Phenytoin—epilepsy syndrome	0.00597	0.0131	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.00597	0.0131	CbGbCtD
Lovastatin—CYP2C19—Trimethadione—epilepsy syndrome	0.00596	0.013	CbGbCtD
Lovastatin—CYP2C19—Felbamate—epilepsy syndrome	0.00596	0.013	CbGbCtD
Lovastatin—ABCB1—Levetiracetam—epilepsy syndrome	0.00565	0.0124	CbGbCtD
Lovastatin—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0056	0.0123	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.00532	0.0116	CbGbCtD
Lovastatin—CYP3A7—Phenobarbital—epilepsy syndrome	0.00532	0.0116	CbGbCtD
Lovastatin—CYP3A7—Midazolam—epilepsy syndrome	0.00524	0.0115	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.00524	0.0115	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00504	0.011	CbGbCtD
Lovastatin—CYP3A7—Diazepam—epilepsy syndrome	0.00504	0.011	CbGbCtD
Lovastatin—CYP3A5—Carbamazepine—epilepsy syndrome	0.00499	0.0109	CbGbCtD
Lovastatin—CYP2C9—Trimethadione—epilepsy syndrome	0.00495	0.0108	CbGbCtD
Lovastatin—CYP2C19—Clobazam—epilepsy syndrome	0.00486	0.0106	CbGbCtD
Lovastatin—CYP2C8—Carbamazepine—epilepsy syndrome	0.0048	0.0105	CbGbCtD
Lovastatin—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00466	0.0102	CbGbCtD
Lovastatin—CYP2C8—Primidone—epilepsy syndrome	0.00448	0.0098	CbGbCtD
Lovastatin—CYP3A5—Phenytoin—epilepsy syndrome	0.00448	0.00979	CbGbCtD
Lovastatin—CYP2C8—Phenytoin—epilepsy syndrome	0.0043	0.00942	CbGbCtD
Lovastatin—CYP2C19—Carbamazepine—epilepsy syndrome	0.00403	0.00881	CbGbCtD
Lovastatin—CYP2C8—Propofol—epilepsy syndrome	0.00401	0.00878	CbGbCtD
Lovastatin—CYP3A5—Phenobarbital—epilepsy syndrome	0.00399	0.00873	CbGbCtD
Lovastatin—CYP3A5—Midazolam—epilepsy syndrome	0.00393	0.00861	CbGbCtD
Lovastatin—ABCB1—Clobazam—epilepsy syndrome	0.00392	0.00858	CbGbCtD
Lovastatin—CYP2C8—Phenobarbital—epilepsy syndrome	0.00384	0.00839	CbGbCtD
Lovastatin—CYP3A5—Diazepam—epilepsy syndrome	0.00378	0.00828	CbGbCtD
Lovastatin—ABCB1—Lamotrigine—epilepsy syndrome	0.00377	0.00826	CbGbCtD
Lovastatin—CYP2C19—Primidone—epilepsy syndrome	0.00376	0.00822	CbGbCtD
Lovastatin—CYP2C8—Diazepam—epilepsy syndrome	0.00364	0.00796	CbGbCtD
Lovastatin—CYP2C19—Phenytoin—epilepsy syndrome	0.00361	0.0079	CbGbCtD
Lovastatin—CYP2C19—Propofol—epilepsy syndrome	0.00337	0.00737	CbGbCtD
Lovastatin—CYP2C9—Carbamazepine—epilepsy syndrome	0.00335	0.00732	CbGbCtD
Lovastatin—ABCB1—Carbamazepine—epilepsy syndrome	0.00325	0.00711	CbGbCtD
Lovastatin—CYP2C19—Phenobarbital—epilepsy syndrome	0.00322	0.00704	CbGbCtD
Lovastatin—CYP2C9—Primidone—epilepsy syndrome	0.00312	0.00684	CbGbCtD
Lovastatin—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0031	0.00678	CbGbCtD
Lovastatin—CYP2C19—Diazepam—epilepsy syndrome	0.00305	0.00668	CbGbCtD
Lovastatin—CYP2C9—Phenytoin—epilepsy syndrome	0.003	0.00657	CbGbCtD
Lovastatin—CYP3A5—Valproic Acid—epilepsy syndrome	0.00298	0.00652	CbGbCtD
Lovastatin—CYP2C19—Zonisamide—epilepsy syndrome	0.00298	0.00652	CbGbCtD
Lovastatin—ABCB1—Phenytoin—epilepsy syndrome	0.00291	0.00637	CbGbCtD
Lovastatin—CYP3A4—Felbamate—epilepsy syndrome	0.00288	0.0063	CbGbCtD
Lovastatin—CYP3A4—Trimethadione—epilepsy syndrome	0.00288	0.0063	CbGbCtD
Lovastatin—CYP2C8—Valproic Acid—epilepsy syndrome	0.00287	0.00627	CbGbCtD
Lovastatin—CYP2C9—Propofol—epilepsy syndrome	0.0028	0.00613	CbGbCtD
Lovastatin—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00271	0.00593	CbGbCtD
Lovastatin—CYP2C9—Phenobarbital—epilepsy syndrome	0.00268	0.00585	CbGbCtD
Lovastatin—ABCB1—Phenobarbital—epilepsy syndrome	0.0026	0.00568	CbGbCtD
Lovastatin—ABCB1—Midazolam—epilepsy syndrome	0.00256	0.0056	CbGbCtD
Lovastatin—CYP2D6—Propofol—epilepsy syndrome	0.00256	0.0056	CbGbCtD
Lovastatin—CYP2C9—Diazepam—epilepsy syndrome	0.00254	0.00555	CbGbCtD
Lovastatin—ABCB1—Diazepam—epilepsy syndrome	0.00246	0.00539	CbGbCtD
Lovastatin—CYP3A4—Clonazepam—epilepsy syndrome	0.00245	0.00536	CbGbCtD
Lovastatin—CYP2C19—Valproic Acid—epilepsy syndrome	0.0024	0.00526	CbGbCtD
Lovastatin—CYP3A4—Clobazam—epilepsy syndrome	0.00235	0.00514	CbGbCtD
Lovastatin—CYP2C19—Topiramate—epilepsy syndrome	0.00217	0.00475	CbGbCtD
Lovastatin—CYP2C9—Valproic Acid—epilepsy syndrome	0.002	0.00437	CbGbCtD
Lovastatin—CYP3A4—Rufinamide—epilepsy syndrome	0.002	0.00437	CbGbCtD
Lovastatin—CYP3A4—Carbamazepine—epilepsy syndrome	0.00195	0.00426	CbGbCtD
Lovastatin—CYP3A4—Primidone—epilepsy syndrome	0.00182	0.00398	CbGbCtD
Lovastatin—CYP3A4—Phenytoin—epilepsy syndrome	0.00175	0.00382	CbGbCtD
Lovastatin—HDAC2—telencephalic ventricle—epilepsy syndrome	0.00173	0.1	CbGeAlD
Lovastatin—CYP3A4—Propofol—epilepsy syndrome	0.00163	0.00356	CbGbCtD
Lovastatin—CYP3A4—Phenobarbital—epilepsy syndrome	0.00156	0.0034	CbGbCtD
Lovastatin—CYP3A4—Acetazolamide—epilepsy syndrome	0.00156	0.0034	CbGbCtD
Lovastatin—CYP3A4—Midazolam—epilepsy syndrome	0.00153	0.00336	CbGbCtD
Lovastatin—CYP3A4—Diazepam—epilepsy syndrome	0.00147	0.00323	CbGbCtD
Lovastatin—CYP3A4—Zonisamide—epilepsy syndrome	0.00144	0.00315	CbGbCtD
Lovastatin—CYP3A4—Valproic Acid—epilepsy syndrome	0.00116	0.00254	CbGbCtD
Lovastatin—HDAC2—tongue—epilepsy syndrome	0.00107	0.0617	CbGeAlD
Lovastatin—CYP3A4—Topiramate—epilepsy syndrome	0.00105	0.0023	CbGbCtD
Lovastatin—HDAC2—hindbrain—epilepsy syndrome	0.000818	0.0473	CbGeAlD
Lovastatin—ITGAL—medulla oblongata—epilepsy syndrome	0.000818	0.0473	CbGeAlD
Lovastatin—ITGAL—midbrain—epilepsy syndrome	0.000747	0.0432	CbGeAlD
Lovastatin—ITGAL—spinal cord—epilepsy syndrome	0.000729	0.0421	CbGeAlD
Lovastatin—Simvastatin—SLCO1A2—epilepsy syndrome	0.000709	0.222	CrCbGaD
Lovastatin—Pravastatin—SLCO1A2—epilepsy syndrome	0.000694	0.217	CrCbGaD
Lovastatin—ITGAL—cerebellum—epilepsy syndrome	0.000578	0.0334	CbGeAlD
Lovastatin—HDAC2—Nortriptyline—Oxcarbazepine—epilepsy syndrome	0.000551	0.57	CbGdCrCtD
Lovastatin—ITGAL—brain—epilepsy syndrome	0.00047	0.0271	CbGeAlD
Lovastatin—HDAC2—brainstem—epilepsy syndrome	0.000469	0.0271	CbGeAlD
Lovastatin—PON3—brain—epilepsy syndrome	0.000461	0.0266	CbGeAlD
Lovastatin—HDAC2—forebrain—epilepsy syndrome	0.000452	0.0261	CbGeAlD
Lovastatin—HDAC2—telencephalon—epilepsy syndrome	0.000416	0.024	CbGeAlD
Lovastatin—HDAC2—Niclosamide—Clonazepam—epilepsy syndrome	0.000416	0.43	CbGdCrCtD
Lovastatin—HMGCR—forebrain—epilepsy syndrome	0.000408	0.0236	CbGeAlD
Lovastatin—HMGCR—telencephalon—epilepsy syndrome	0.000375	0.0217	CbGeAlD
Lovastatin—Simvastatin—ABCC2—epilepsy syndrome	0.000339	0.106	CrCbGaD
Lovastatin—Pravastatin—ABCC2—epilepsy syndrome	0.000332	0.104	CrCbGaD
Lovastatin—HDAC2—medulla oblongata—epilepsy syndrome	0.000327	0.0189	CbGeAlD
Lovastatin—SLCO1A2—forebrain—epilepsy syndrome	0.000318	0.0184	CbGeAlD
Lovastatin—HDAC2—midbrain—epilepsy syndrome	0.000299	0.0173	CbGeAlD
Lovastatin—HMGCR—medulla oblongata—epilepsy syndrome	0.000295	0.017	CbGeAlD
Lovastatin—Pravastatin—ABCG2—epilepsy syndrome	0.000293	0.0918	CrCbGaD
Lovastatin—SLCO1A2—telencephalon—epilepsy syndrome	0.000293	0.0169	CbGeAlD
Lovastatin—HMGCR—midbrain—epilepsy syndrome	0.00027	0.0156	CbGeAlD
Lovastatin—CYP2D6—hindbrain—epilepsy syndrome	0.000268	0.0155	CbGeAlD
Lovastatin—HMGCR—spinal cord—epilepsy syndrome	0.000263	0.0152	CbGeAlD
Lovastatin—HDAC2—head—epilepsy syndrome	0.000259	0.015	CbGeAlD
Lovastatin—HDAC2—nervous system—epilepsy syndrome	0.000246	0.0142	CbGeAlD
Lovastatin—HDAC2—central nervous system—epilepsy syndrome	0.000236	0.0137	CbGeAlD
Lovastatin—Simvastatin—CYP2C19—epilepsy syndrome	0.000236	0.0737	CrCbGaD
Lovastatin—HMGCR—head—epilepsy syndrome	0.000234	0.0135	CbGeAlD
Lovastatin—HDAC2—cerebellum—epilepsy syndrome	0.000231	0.0134	CbGeAlD
Lovastatin—SLCO1A2—medulla oblongata—epilepsy syndrome	0.00023	0.0133	CbGeAlD
Lovastatin—HMGCR—nervous system—epilepsy syndrome	0.000222	0.0128	CbGeAlD
Lovastatin—HMGCR—central nervous system—epilepsy syndrome	0.000213	0.0123	CbGeAlD
Lovastatin—SLCO1A2—midbrain—epilepsy syndrome	0.00021	0.0121	CbGeAlD
Lovastatin—HMGCR—cerebellum—epilepsy syndrome	0.000209	0.0121	CbGeAlD
Lovastatin—SLCO1A2—spinal cord—epilepsy syndrome	0.000205	0.0118	CbGeAlD
Lovastatin—HDAC2—brain—epilepsy syndrome	0.000188	0.0108	CbGeAlD
Lovastatin—SLCO1A2—head—epilepsy syndrome	0.000182	0.0105	CbGeAlD
Lovastatin—Simvastatin—CYP2D6—epilepsy syndrome	0.000175	0.0547	CrCbGaD
Lovastatin—SLCO1A2—nervous system—epilepsy syndrome	0.000173	0.00998	CbGeAlD
Lovastatin—Pravastatin—CYP2D6—epilepsy syndrome	0.000171	0.0535	CrCbGaD
Lovastatin—HMGCR—brain—epilepsy syndrome	0.000169	0.00979	CbGeAlD
Lovastatin—SLCO1A2—central nervous system—epilepsy syndrome	0.000166	0.00961	CbGeAlD
Lovastatin—SLCO1A2—cerebellum—epilepsy syndrome	0.000163	0.0094	CbGeAlD
Lovastatin—CYP2D6—brainstem—epilepsy syndrome	0.000154	0.00887	CbGeAlD
Lovastatin—CYP2D6—forebrain—epilepsy syndrome	0.000148	0.00857	CbGeAlD
Lovastatin—CYP2D6—telencephalon—epilepsy syndrome	0.000136	0.00788	CbGeAlD
Lovastatin—SLCO1A2—brain—epilepsy syndrome	0.000132	0.00763	CbGeAlD
Lovastatin—Simvastatin—ABCB1—epilepsy syndrome	0.000125	0.039	CrCbGaD
Lovastatin—Pravastatin—ABCB1—epilepsy syndrome	0.000122	0.0382	CrCbGaD
Lovastatin—ABCB1—forebrain—epilepsy syndrome	0.000107	0.00616	CbGeAlD
Lovastatin—ABCB1—telencephalon—epilepsy syndrome	9.8e-05	0.00567	CbGeAlD
Lovastatin—CYP2C8—brain—epilepsy syndrome	9.23e-05	0.00533	CbGeAlD
Lovastatin—CYP2D6—head—epilepsy syndrome	8.49e-05	0.0049	CbGeAlD
Lovastatin—CYP3A4—nervous system—epilepsy syndrome	8.18e-05	0.00473	CbGeAlD
Lovastatin—CYP2D6—nervous system—epilepsy syndrome	8.05e-05	0.00465	CbGeAlD
Lovastatin—CYP3A4—central nervous system—epilepsy syndrome	7.87e-05	0.00455	CbGeAlD
Lovastatin—CYP2D6—central nervous system—epilepsy syndrome	7.75e-05	0.00448	CbGeAlD
Lovastatin—ABCB1—medulla oblongata—epilepsy syndrome	7.7e-05	0.00445	CbGeAlD
Lovastatin—CYP2D6—cerebellum—epilepsy syndrome	7.57e-05	0.00438	CbGeAlD
Lovastatin—ABCB1—midbrain—epilepsy syndrome	7.04e-05	0.00407	CbGeAlD
Lovastatin—ABCB1—spinal cord—epilepsy syndrome	6.87e-05	0.00397	CbGeAlD
Lovastatin—CYP2D6—brain—epilepsy syndrome	6.15e-05	0.00355	CbGeAlD
Lovastatin—ABCB1—head—epilepsy syndrome	6.1e-05	0.00353	CbGeAlD
Lovastatin—ABCB1—nervous system—epilepsy syndrome	5.79e-05	0.00334	CbGeAlD
Lovastatin—ABCB1—central nervous system—epilepsy syndrome	5.57e-05	0.00322	CbGeAlD
Lovastatin—ABCB1—cerebellum—epilepsy syndrome	5.45e-05	0.00315	CbGeAlD
Lovastatin—Angioedema—Pregabalin—epilepsy syndrome	4.9e-05	0.00038	CcSEcCtD
Lovastatin—Hypersensitivity—Clonazepam—epilepsy syndrome	4.9e-05	0.000379	CcSEcCtD
Lovastatin—Dizziness—Vigabatrin—epilepsy syndrome	4.9e-05	0.000379	CcSEcCtD
Lovastatin—Confusional state—Valproic Acid—epilepsy syndrome	4.89e-05	0.000378	CcSEcCtD
Lovastatin—Pruritus—Zonisamide—epilepsy syndrome	4.89e-05	0.000378	CcSEcCtD
Lovastatin—Hypersensitivity—Phenytoin—epilepsy syndrome	4.87e-05	0.000377	CcSEcCtD
Lovastatin—Flatulence—Gabapentin—epilepsy syndrome	4.85e-05	0.000375	CcSEcCtD
Lovastatin—Anaphylactic shock—Valproic Acid—epilepsy syndrome	4.85e-05	0.000375	CcSEcCtD
Lovastatin—Urticaria—Lamotrigine—epilepsy syndrome	4.84e-05	0.000375	CcSEcCtD
Lovastatin—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	4.84e-05	0.000375	CcSEcCtD
Lovastatin—Malaise—Pregabalin—epilepsy syndrome	4.84e-05	0.000375	CcSEcCtD
Lovastatin—Nausea—Propofol—epilepsy syndrome	4.84e-05	0.000374	CcSEcCtD
Lovastatin—Vomiting—Fosphenytoin—epilepsy syndrome	4.83e-05	0.000374	CcSEcCtD
Lovastatin—Diarrhoea—Felbamate—epilepsy syndrome	4.83e-05	0.000373	CcSEcCtD
Lovastatin—Vertigo—Pregabalin—epilepsy syndrome	4.82e-05	0.000373	CcSEcCtD
Lovastatin—Abdominal pain—Lamotrigine—epilepsy syndrome	4.82e-05	0.000373	CcSEcCtD
Lovastatin—Body temperature increased—Lamotrigine—epilepsy syndrome	4.82e-05	0.000373	CcSEcCtD
Lovastatin—Dysgeusia—Gabapentin—epilepsy syndrome	4.82e-05	0.000373	CcSEcCtD
Lovastatin—Dizziness—Diazepam—epilepsy syndrome	4.82e-05	0.000373	CcSEcCtD
Lovastatin—Infection—Valproic Acid—epilepsy syndrome	4.81e-05	0.000373	CcSEcCtD
Lovastatin—Leukopenia—Pregabalin—epilepsy syndrome	4.8e-05	0.000372	CcSEcCtD
Lovastatin—Rash—Fosphenytoin—epilepsy syndrome	4.79e-05	0.000371	CcSEcCtD
Lovastatin—Dermatitis—Fosphenytoin—epilepsy syndrome	4.78e-05	0.00037	CcSEcCtD
Lovastatin—Asthenia—Clonazepam—epilepsy syndrome	4.77e-05	0.000369	CcSEcCtD
Lovastatin—Back pain—Gabapentin—epilepsy syndrome	4.76e-05	0.000368	CcSEcCtD
Lovastatin—Headache—Fosphenytoin—epilepsy syndrome	4.76e-05	0.000368	CcSEcCtD
Lovastatin—Hepatitis—Topiramate—epilepsy syndrome	4.76e-05	0.000368	CcSEcCtD
Lovastatin—Thrombocytopenia—Valproic Acid—epilepsy syndrome	4.74e-05	0.000367	CcSEcCtD
Lovastatin—Asthenia—Phenytoin—epilepsy syndrome	4.74e-05	0.000367	CcSEcCtD
Lovastatin—Nausea—Midazolam—epilepsy syndrome	4.73e-05	0.000366	CcSEcCtD
Lovastatin—Muscle spasms—Gabapentin—epilepsy syndrome	4.73e-05	0.000366	CcSEcCtD
Lovastatin—Diarrhoea—Zonisamide—epilepsy syndrome	4.72e-05	0.000366	CcSEcCtD
Lovastatin—Asthenia—Oxcarbazepine—epilepsy syndrome	4.72e-05	0.000365	CcSEcCtD
Lovastatin—Pruritus—Clonazepam—epilepsy syndrome	4.71e-05	0.000364	CcSEcCtD
Lovastatin—Vomiting—Vigabatrin—epilepsy syndrome	4.71e-05	0.000364	CcSEcCtD
Lovastatin—Pruritus—Phenytoin—epilepsy syndrome	4.68e-05	0.000362	CcSEcCtD
Lovastatin—Nausea—Levetiracetam—epilepsy syndrome	4.67e-05	0.000362	CcSEcCtD
Lovastatin—Rash—Vigabatrin—epilepsy syndrome	4.67e-05	0.000361	CcSEcCtD
Lovastatin—Dizziness—Felbamate—epilepsy syndrome	4.66e-05	0.000361	CcSEcCtD
Lovastatin—Dermatitis—Vigabatrin—epilepsy syndrome	4.66e-05	0.000361	CcSEcCtD
Lovastatin—Pruritus—Oxcarbazepine—epilepsy syndrome	4.65e-05	0.00036	CcSEcCtD
Lovastatin—Hypersensitivity—Carbamazepine—epilepsy syndrome	4.65e-05	0.00036	CcSEcCtD
Lovastatin—Vision blurred—Gabapentin—epilepsy syndrome	4.64e-05	0.000359	CcSEcCtD
Lovastatin—Headache—Vigabatrin—epilepsy syndrome	4.64e-05	0.000359	CcSEcCtD
Lovastatin—Vomiting—Diazepam—epilepsy syndrome	4.63e-05	0.000359	CcSEcCtD
Lovastatin—Anorexia—Valproic Acid—epilepsy syndrome	4.62e-05	0.000357	CcSEcCtD
Lovastatin—Tremor—Gabapentin—epilepsy syndrome	4.61e-05	0.000357	CcSEcCtD
Lovastatin—Rash—Diazepam—epilepsy syndrome	4.6e-05	0.000356	CcSEcCtD
Lovastatin—Dermatitis—Diazepam—epilepsy syndrome	4.59e-05	0.000355	CcSEcCtD
Lovastatin—Arthralgia—Pregabalin—epilepsy syndrome	4.57e-05	0.000354	CcSEcCtD
Lovastatin—Chest pain—Pregabalin—epilepsy syndrome	4.57e-05	0.000354	CcSEcCtD
Lovastatin—Myalgia—Pregabalin—epilepsy syndrome	4.57e-05	0.000354	CcSEcCtD
Lovastatin—Ill-defined disorder—Gabapentin—epilepsy syndrome	4.57e-05	0.000353	CcSEcCtD
Lovastatin—Dizziness—Zonisamide—epilepsy syndrome	4.57e-05	0.000353	CcSEcCtD
Lovastatin—Headache—Diazepam—epilepsy syndrome	4.57e-05	0.000353	CcSEcCtD
Lovastatin—Anxiety—Pregabalin—epilepsy syndrome	4.55e-05	0.000352	CcSEcCtD
Lovastatin—Diarrhoea—Clonazepam—epilepsy syndrome	4.55e-05	0.000352	CcSEcCtD
Lovastatin—Asthenia—Carbamazepine—epilepsy syndrome	4.53e-05	0.00035	CcSEcCtD
Lovastatin—Diarrhoea—Phenytoin—epilepsy syndrome	4.52e-05	0.00035	CcSEcCtD
Lovastatin—Discomfort—Pregabalin—epilepsy syndrome	4.52e-05	0.000349	CcSEcCtD
Lovastatin—Nausea—Fosphenytoin—epilepsy syndrome	4.51e-05	0.000349	CcSEcCtD
Lovastatin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.5e-05	0.000348	CcSEcCtD
Lovastatin—Erythema multiforme—Topiramate—epilepsy syndrome	4.5e-05	0.000348	CcSEcCtD
Lovastatin—Angioedema—Gabapentin—epilepsy syndrome	4.5e-05	0.000348	CcSEcCtD
Lovastatin—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.49e-05	0.000348	CcSEcCtD
Lovastatin—Vomiting—Felbamate—epilepsy syndrome	4.49e-05	0.000347	CcSEcCtD
Lovastatin—Dry mouth—Pregabalin—epilepsy syndrome	4.47e-05	0.000346	CcSEcCtD
Lovastatin—Pruritus—Carbamazepine—epilepsy syndrome	4.46e-05	0.000345	CcSEcCtD
Lovastatin—Rash—Felbamate—epilepsy syndrome	4.45e-05	0.000344	CcSEcCtD
Lovastatin—Dermatitis—Felbamate—epilepsy syndrome	4.44e-05	0.000344	CcSEcCtD
Lovastatin—Malaise—Gabapentin—epilepsy syndrome	4.44e-05	0.000343	CcSEcCtD
Lovastatin—ABCB1—brain—epilepsy syndrome	4.42e-05	0.00256	CbGeAlD
Lovastatin—Vertigo—Gabapentin—epilepsy syndrome	4.42e-05	0.000342	CcSEcCtD
Lovastatin—Headache—Felbamate—epilepsy syndrome	4.42e-05	0.000342	CcSEcCtD
Lovastatin—Confusional state—Pregabalin—epilepsy syndrome	4.42e-05	0.000342	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4.41e-05	0.000342	CcSEcCtD
Lovastatin—Flushing—Topiramate—epilepsy syndrome	4.41e-05	0.000342	CcSEcCtD
Lovastatin—Leukopenia—Gabapentin—epilepsy syndrome	4.41e-05	0.000341	CcSEcCtD
Lovastatin—Dizziness—Clonazepam—epilepsy syndrome	4.4e-05	0.000341	CcSEcCtD
Lovastatin—Nausea—Vigabatrin—epilepsy syndrome	4.4e-05	0.00034	CcSEcCtD
Lovastatin—Vomiting—Zonisamide—epilepsy syndrome	4.39e-05	0.00034	CcSEcCtD
Lovastatin—Insomnia—Valproic Acid—epilepsy syndrome	4.38e-05	0.000339	CcSEcCtD
Lovastatin—Anaphylactic shock—Pregabalin—epilepsy syndrome	4.38e-05	0.000339	CcSEcCtD
Lovastatin—Asthenia—Lamotrigine—epilepsy syndrome	4.38e-05	0.000339	CcSEcCtD
Lovastatin—Dizziness—Phenytoin—epilepsy syndrome	4.37e-05	0.000338	CcSEcCtD
Lovastatin—Rash—Zonisamide—epilepsy syndrome	4.35e-05	0.000337	CcSEcCtD
Lovastatin—Infection—Pregabalin—epilepsy syndrome	4.35e-05	0.000337	CcSEcCtD
Lovastatin—Paraesthesia—Valproic Acid—epilepsy syndrome	4.35e-05	0.000337	CcSEcCtD
Lovastatin—Dermatitis—Zonisamide—epilepsy syndrome	4.35e-05	0.000337	CcSEcCtD
Lovastatin—Dizziness—Oxcarbazepine—epilepsy syndrome	4.35e-05	0.000336	CcSEcCtD
Lovastatin—Nausea—Diazepam—epilepsy syndrome	4.33e-05	0.000335	CcSEcCtD
Lovastatin—Headache—Zonisamide—epilepsy syndrome	4.33e-05	0.000335	CcSEcCtD
Lovastatin—Dyspnoea—Valproic Acid—epilepsy syndrome	4.32e-05	0.000334	CcSEcCtD
Lovastatin—Diarrhoea—Carbamazepine—epilepsy syndrome	4.32e-05	0.000334	CcSEcCtD
Lovastatin—Pruritus—Lamotrigine—epilepsy syndrome	4.31e-05	0.000334	CcSEcCtD
Lovastatin—Thrombocytopenia—Pregabalin—epilepsy syndrome	4.29e-05	0.000332	CcSEcCtD
Lovastatin—Chills—Topiramate—epilepsy syndrome	4.27e-05	0.00033	CcSEcCtD
Lovastatin—Dyspepsia—Valproic Acid—epilepsy syndrome	4.27e-05	0.00033	CcSEcCtD
Lovastatin—Vomiting—Clonazepam—epilepsy syndrome	4.23e-05	0.000327	CcSEcCtD
Lovastatin—Decreased appetite—Valproic Acid—epilepsy syndrome	4.21e-05	0.000326	CcSEcCtD
Lovastatin—Alopecia—Topiramate—epilepsy syndrome	4.2e-05	0.000325	CcSEcCtD
Lovastatin—Vomiting—Phenytoin—epilepsy syndrome	4.2e-05	0.000325	CcSEcCtD
Lovastatin—Rash—Clonazepam—epilepsy syndrome	4.2e-05	0.000325	CcSEcCtD
Lovastatin—Dermatitis—Clonazepam—epilepsy syndrome	4.19e-05	0.000324	CcSEcCtD
Lovastatin—Myalgia—Gabapentin—epilepsy syndrome	4.19e-05	0.000324	CcSEcCtD
Lovastatin—Arthralgia—Gabapentin—epilepsy syndrome	4.19e-05	0.000324	CcSEcCtD
Lovastatin—Chest pain—Gabapentin—epilepsy syndrome	4.19e-05	0.000324	CcSEcCtD
Lovastatin—Nausea—Felbamate—epilepsy syndrome	4.19e-05	0.000324	CcSEcCtD
Lovastatin—Vomiting—Oxcarbazepine—epilepsy syndrome	4.18e-05	0.000324	CcSEcCtD
Lovastatin—Fatigue—Valproic Acid—epilepsy syndrome	4.18e-05	0.000323	CcSEcCtD
Lovastatin—Anxiety—Gabapentin—epilepsy syndrome	4.18e-05	0.000323	CcSEcCtD
Lovastatin—Anorexia—Pregabalin—epilepsy syndrome	4.18e-05	0.000323	CcSEcCtD
Lovastatin—Dizziness—Carbamazepine—epilepsy syndrome	4.17e-05	0.000323	CcSEcCtD
Lovastatin—Diarrhoea—Lamotrigine—epilepsy syndrome	4.17e-05	0.000323	CcSEcCtD
Lovastatin—Headache—Clonazepam—epilepsy syndrome	4.17e-05	0.000323	CcSEcCtD
Lovastatin—Rash—Phenytoin—epilepsy syndrome	4.17e-05	0.000323	CcSEcCtD
Lovastatin—Dermatitis—Phenytoin—epilepsy syndrome	4.16e-05	0.000322	CcSEcCtD
Lovastatin—Rash—Oxcarbazepine—epilepsy syndrome	4.15e-05	0.000321	CcSEcCtD
Lovastatin—Constipation—Valproic Acid—epilepsy syndrome	4.14e-05	0.000321	CcSEcCtD
Lovastatin—Pain—Valproic Acid—epilepsy syndrome	4.14e-05	0.000321	CcSEcCtD
Lovastatin—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.14e-05	0.000321	CcSEcCtD
Lovastatin—Headache—Phenytoin—epilepsy syndrome	4.14e-05	0.00032	CcSEcCtD
Lovastatin—Discomfort—Gabapentin—epilepsy syndrome	4.14e-05	0.00032	CcSEcCtD
Lovastatin—Headache—Oxcarbazepine—epilepsy syndrome	4.12e-05	0.000319	CcSEcCtD
Lovastatin—Nausea—Zonisamide—epilepsy syndrome	4.1e-05	0.000317	CcSEcCtD
Lovastatin—Dry mouth—Gabapentin—epilepsy syndrome	4.1e-05	0.000317	CcSEcCtD
Lovastatin—Flatulence—Topiramate—epilepsy syndrome	4.08e-05	0.000316	CcSEcCtD
Lovastatin—Dysgeusia—Topiramate—epilepsy syndrome	4.06e-05	0.000314	CcSEcCtD
Lovastatin—Confusional state—Gabapentin—epilepsy syndrome	4.05e-05	0.000313	CcSEcCtD
Lovastatin—Dizziness—Lamotrigine—epilepsy syndrome	4.03e-05	0.000312	CcSEcCtD
Lovastatin—Anaphylactic shock—Gabapentin—epilepsy syndrome	4.02e-05	0.000311	CcSEcCtD
Lovastatin—Vomiting—Carbamazepine—epilepsy syndrome	4.01e-05	0.00031	CcSEcCtD
Lovastatin—Back pain—Topiramate—epilepsy syndrome	4.01e-05	0.00031	CcSEcCtD
Lovastatin—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.99e-05	0.000309	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.99e-05	0.000309	CcSEcCtD
Lovastatin—Infection—Gabapentin—epilepsy syndrome	3.99e-05	0.000309	CcSEcCtD
Lovastatin—Muscle spasms—Topiramate—epilepsy syndrome	3.98e-05	0.000308	CcSEcCtD
Lovastatin—Rash—Carbamazepine—epilepsy syndrome	3.98e-05	0.000308	CcSEcCtD
Lovastatin—Dermatitis—Carbamazepine—epilepsy syndrome	3.97e-05	0.000308	CcSEcCtD
Lovastatin—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.96e-05	0.000307	CcSEcCtD
Lovastatin—Insomnia—Pregabalin—epilepsy syndrome	3.96e-05	0.000307	CcSEcCtD
Lovastatin—Nausea—Clonazepam—epilepsy syndrome	3.95e-05	0.000306	CcSEcCtD
Lovastatin—Headache—Carbamazepine—epilepsy syndrome	3.95e-05	0.000306	CcSEcCtD
Lovastatin—Paraesthesia—Pregabalin—epilepsy syndrome	3.93e-05	0.000304	CcSEcCtD
Lovastatin—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.93e-05	0.000304	CcSEcCtD
Lovastatin—Nausea—Phenytoin—epilepsy syndrome	3.93e-05	0.000304	CcSEcCtD
Lovastatin—Dyspnoea—Pregabalin—epilepsy syndrome	3.91e-05	0.000302	CcSEcCtD
Lovastatin—Nausea—Oxcarbazepine—epilepsy syndrome	3.91e-05	0.000302	CcSEcCtD
Lovastatin—Vision blurred—Topiramate—epilepsy syndrome	3.9e-05	0.000302	CcSEcCtD
Lovastatin—Tremor—Topiramate—epilepsy syndrome	3.88e-05	0.0003	CcSEcCtD
Lovastatin—Vomiting—Lamotrigine—epilepsy syndrome	3.88e-05	0.0003	CcSEcCtD
Lovastatin—Urticaria—Valproic Acid—epilepsy syndrome	3.85e-05	0.000298	CcSEcCtD
Lovastatin—Rash—Lamotrigine—epilepsy syndrome	3.84e-05	0.000298	CcSEcCtD
Lovastatin—Ill-defined disorder—Topiramate—epilepsy syndrome	3.84e-05	0.000297	CcSEcCtD
Lovastatin—Dermatitis—Lamotrigine—epilepsy syndrome	3.84e-05	0.000297	CcSEcCtD
Lovastatin—Abdominal pain—Valproic Acid—epilepsy syndrome	3.83e-05	0.000296	CcSEcCtD
Lovastatin—Body temperature increased—Valproic Acid—epilepsy syndrome	3.83e-05	0.000296	CcSEcCtD
Lovastatin—Anorexia—Gabapentin—epilepsy syndrome	3.83e-05	0.000296	CcSEcCtD
Lovastatin—Headache—Lamotrigine—epilepsy syndrome	3.82e-05	0.000296	CcSEcCtD
Lovastatin—Decreased appetite—Pregabalin—epilepsy syndrome	3.81e-05	0.000295	CcSEcCtD
Lovastatin—Fatigue—Pregabalin—epilepsy syndrome	3.78e-05	0.000292	CcSEcCtD
Lovastatin—Nausea—Carbamazepine—epilepsy syndrome	3.75e-05	0.00029	CcSEcCtD
Lovastatin—Constipation—Pregabalin—epilepsy syndrome	3.75e-05	0.00029	CcSEcCtD
Lovastatin—Pain—Pregabalin—epilepsy syndrome	3.75e-05	0.00029	CcSEcCtD
Lovastatin—Malaise—Topiramate—epilepsy syndrome	3.73e-05	0.000289	CcSEcCtD
Lovastatin—Vertigo—Topiramate—epilepsy syndrome	3.72e-05	0.000288	CcSEcCtD
Lovastatin—Leukopenia—Topiramate—epilepsy syndrome	3.71e-05	0.000287	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.66e-05	0.000283	CcSEcCtD
Lovastatin—Insomnia—Gabapentin—epilepsy syndrome	3.63e-05	0.000281	CcSEcCtD
Lovastatin—Nausea—Lamotrigine—epilepsy syndrome	3.62e-05	0.00028	CcSEcCtD
Lovastatin—Feeling abnormal—Pregabalin—epilepsy syndrome	3.61e-05	0.000279	CcSEcCtD
Lovastatin—Paraesthesia—Gabapentin—epilepsy syndrome	3.61e-05	0.000279	CcSEcCtD
Lovastatin—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.58e-05	0.000277	CcSEcCtD
Lovastatin—Dyspnoea—Gabapentin—epilepsy syndrome	3.58e-05	0.000277	CcSEcCtD
Lovastatin—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.57e-05	0.000276	CcSEcCtD
Lovastatin—Dyspepsia—Gabapentin—epilepsy syndrome	3.54e-05	0.000274	CcSEcCtD
Lovastatin—Chest pain—Topiramate—epilepsy syndrome	3.53e-05	0.000273	CcSEcCtD
Lovastatin—Arthralgia—Topiramate—epilepsy syndrome	3.53e-05	0.000273	CcSEcCtD
Lovastatin—Myalgia—Topiramate—epilepsy syndrome	3.53e-05	0.000273	CcSEcCtD
Lovastatin—Anxiety—Topiramate—epilepsy syndrome	3.51e-05	0.000272	CcSEcCtD
Lovastatin—Decreased appetite—Gabapentin—epilepsy syndrome	3.49e-05	0.00027	CcSEcCtD
Lovastatin—Discomfort—Topiramate—epilepsy syndrome	3.48e-05	0.00027	CcSEcCtD
Lovastatin—Urticaria—Pregabalin—epilepsy syndrome	3.48e-05	0.000269	CcSEcCtD
Lovastatin—Asthenia—Valproic Acid—epilepsy syndrome	3.48e-05	0.000269	CcSEcCtD
Lovastatin—Fatigue—Gabapentin—epilepsy syndrome	3.46e-05	0.000268	CcSEcCtD
Lovastatin—Abdominal pain—Pregabalin—epilepsy syndrome	3.46e-05	0.000268	CcSEcCtD
Lovastatin—Body temperature increased—Pregabalin—epilepsy syndrome	3.46e-05	0.000268	CcSEcCtD
Lovastatin—Dry mouth—Topiramate—epilepsy syndrome	3.45e-05	0.000267	CcSEcCtD
Lovastatin—Constipation—Gabapentin—epilepsy syndrome	3.44e-05	0.000266	CcSEcCtD
Lovastatin—Pain—Gabapentin—epilepsy syndrome	3.44e-05	0.000266	CcSEcCtD
Lovastatin—Pruritus—Valproic Acid—epilepsy syndrome	3.43e-05	0.000265	CcSEcCtD
Lovastatin—Confusional state—Topiramate—epilepsy syndrome	3.41e-05	0.000264	CcSEcCtD
Lovastatin—Infection—Topiramate—epilepsy syndrome	3.36e-05	0.00026	CcSEcCtD
Lovastatin—Diarrhoea—Valproic Acid—epilepsy syndrome	3.32e-05	0.000257	CcSEcCtD
Lovastatin—Feeling abnormal—Gabapentin—epilepsy syndrome	3.31e-05	0.000256	CcSEcCtD
Lovastatin—Thrombocytopenia—Topiramate—epilepsy syndrome	3.31e-05	0.000256	CcSEcCtD
Lovastatin—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.28e-05	0.000254	CcSEcCtD
Lovastatin—Hypersensitivity—Pregabalin—epilepsy syndrome	3.23e-05	0.00025	CcSEcCtD
Lovastatin—Anorexia—Topiramate—epilepsy syndrome	3.22e-05	0.000249	CcSEcCtD
Lovastatin—Dizziness—Valproic Acid—epilepsy syndrome	3.2e-05	0.000248	CcSEcCtD
Lovastatin—Urticaria—Gabapentin—epilepsy syndrome	3.19e-05	0.000247	CcSEcCtD
Lovastatin—Body temperature increased—Gabapentin—epilepsy syndrome	3.18e-05	0.000246	CcSEcCtD
Lovastatin—Abdominal pain—Gabapentin—epilepsy syndrome	3.18e-05	0.000246	CcSEcCtD
Lovastatin—Asthenia—Pregabalin—epilepsy syndrome	3.14e-05	0.000243	CcSEcCtD
Lovastatin—Pruritus—Pregabalin—epilepsy syndrome	3.1e-05	0.00024	CcSEcCtD
Lovastatin—Vomiting—Valproic Acid—epilepsy syndrome	3.08e-05	0.000238	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.08e-05	0.000238	CcSEcCtD
Lovastatin—Insomnia—Topiramate—epilepsy syndrome	3.06e-05	0.000237	CcSEcCtD
Lovastatin—Rash—Valproic Acid—epilepsy syndrome	3.06e-05	0.000236	CcSEcCtD
Lovastatin—Dermatitis—Valproic Acid—epilepsy syndrome	3.05e-05	0.000236	CcSEcCtD
Lovastatin—Headache—Valproic Acid—epilepsy syndrome	3.04e-05	0.000235	CcSEcCtD
Lovastatin—Paraesthesia—Topiramate—epilepsy syndrome	3.03e-05	0.000235	CcSEcCtD
Lovastatin—Dyspnoea—Topiramate—epilepsy syndrome	3.01e-05	0.000233	CcSEcCtD
Lovastatin—Diarrhoea—Pregabalin—epilepsy syndrome	3e-05	0.000232	CcSEcCtD
Lovastatin—Dyspepsia—Topiramate—epilepsy syndrome	2.97e-05	0.00023	CcSEcCtD
Lovastatin—Hypersensitivity—Gabapentin—epilepsy syndrome	2.96e-05	0.000229	CcSEcCtD
Lovastatin—Decreased appetite—Topiramate—epilepsy syndrome	2.94e-05	0.000227	CcSEcCtD
Lovastatin—Fatigue—Topiramate—epilepsy syndrome	2.91e-05	0.000225	CcSEcCtD
Lovastatin—Dizziness—Pregabalin—epilepsy syndrome	2.9e-05	0.000224	CcSEcCtD
Lovastatin—Constipation—Topiramate—epilepsy syndrome	2.89e-05	0.000224	CcSEcCtD
Lovastatin—Pain—Topiramate—epilepsy syndrome	2.89e-05	0.000224	CcSEcCtD
Lovastatin—Asthenia—Gabapentin—epilepsy syndrome	2.88e-05	0.000223	CcSEcCtD
Lovastatin—Nausea—Valproic Acid—epilepsy syndrome	2.88e-05	0.000223	CcSEcCtD
Lovastatin—Pruritus—Gabapentin—epilepsy syndrome	2.84e-05	0.00022	CcSEcCtD
Lovastatin—Vomiting—Pregabalin—epilepsy syndrome	2.79e-05	0.000216	CcSEcCtD
Lovastatin—Feeling abnormal—Topiramate—epilepsy syndrome	2.78e-05	0.000216	CcSEcCtD
Lovastatin—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.76e-05	0.000214	CcSEcCtD
Lovastatin—Rash—Pregabalin—epilepsy syndrome	2.76e-05	0.000214	CcSEcCtD
Lovastatin—Dermatitis—Pregabalin—epilepsy syndrome	2.76e-05	0.000214	CcSEcCtD
Lovastatin—Diarrhoea—Gabapentin—epilepsy syndrome	2.75e-05	0.000213	CcSEcCtD
Lovastatin—Headache—Pregabalin—epilepsy syndrome	2.74e-05	0.000212	CcSEcCtD
Lovastatin—Urticaria—Topiramate—epilepsy syndrome	2.68e-05	0.000208	CcSEcCtD
Lovastatin—Abdominal pain—Topiramate—epilepsy syndrome	2.67e-05	0.000207	CcSEcCtD
Lovastatin—Body temperature increased—Topiramate—epilepsy syndrome	2.67e-05	0.000207	CcSEcCtD
Lovastatin—Dizziness—Gabapentin—epilepsy syndrome	2.66e-05	0.000206	CcSEcCtD
Lovastatin—Nausea—Pregabalin—epilepsy syndrome	2.6e-05	0.000201	CcSEcCtD
Lovastatin—Vomiting—Gabapentin—epilepsy syndrome	2.55e-05	0.000198	CcSEcCtD
Lovastatin—Rash—Gabapentin—epilepsy syndrome	2.53e-05	0.000196	CcSEcCtD
Lovastatin—Dermatitis—Gabapentin—epilepsy syndrome	2.53e-05	0.000196	CcSEcCtD
Lovastatin—Headache—Gabapentin—epilepsy syndrome	2.52e-05	0.000195	CcSEcCtD
Lovastatin—Hypersensitivity—Topiramate—epilepsy syndrome	2.49e-05	0.000193	CcSEcCtD
Lovastatin—Asthenia—Topiramate—epilepsy syndrome	2.42e-05	0.000188	CcSEcCtD
Lovastatin—Pruritus—Topiramate—epilepsy syndrome	2.39e-05	0.000185	CcSEcCtD
Lovastatin—Nausea—Gabapentin—epilepsy syndrome	2.39e-05	0.000185	CcSEcCtD
Lovastatin—Diarrhoea—Topiramate—epilepsy syndrome	2.31e-05	0.000179	CcSEcCtD
Lovastatin—Dizziness—Topiramate—epilepsy syndrome	2.23e-05	0.000173	CcSEcCtD
Lovastatin—Vomiting—Topiramate—epilepsy syndrome	2.15e-05	0.000166	CcSEcCtD
Lovastatin—Rash—Topiramate—epilepsy syndrome	2.13e-05	0.000165	CcSEcCtD
Lovastatin—Dermatitis—Topiramate—epilepsy syndrome	2.13e-05	0.000165	CcSEcCtD
Lovastatin—Headache—Topiramate—epilepsy syndrome	2.12e-05	0.000164	CcSEcCtD
Lovastatin—Nausea—Topiramate—epilepsy syndrome	2.01e-05	0.000155	CcSEcCtD
Lovastatin—SLCO1A2—Metabolism—GPX1—epilepsy syndrome	3.38e-06	5.32e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—POMC—epilepsy syndrome	3.37e-06	5.31e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—APOE—epilepsy syndrome	3.33e-06	5.25e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.33e-06	5.24e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ABCG2—epilepsy syndrome	3.3e-06	5.21e-05	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PTGS2—epilepsy syndrome	3.3e-06	5.19e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TSC2—epilepsy syndrome	3.29e-06	5.18e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	3.28e-06	5.17e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—AGT—epilepsy syndrome	3.28e-06	5.17e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.27e-06	5.15e-05	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—AKT1—epilepsy syndrome	3.27e-06	5.15e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	3.25e-06	5.13e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—HMOX1—epilepsy syndrome	3.24e-06	5.1e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CYP2C19—epilepsy syndrome	3.22e-06	5.07e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—APOE—epilepsy syndrome	3.21e-06	5.07e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.2e-06	5.05e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CYP11A1—epilepsy syndrome	3.2e-06	5.04e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—CAT—epilepsy syndrome	3.19e-06	5.03e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—AQP1—epilepsy syndrome	3.19e-06	5.02e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MTOR—epilepsy syndrome	3.17e-06	5e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—AQP1—epilepsy syndrome	3.16e-06	4.98e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GPX1—epilepsy syndrome	3.15e-06	4.97e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—KDR—epilepsy syndrome	3.15e-06	4.96e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PTGS2—epilepsy syndrome	3.15e-06	4.96e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—UPB1—epilepsy syndrome	3.14e-06	4.96e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NEU1—epilepsy syndrome	3.14e-06	4.96e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ATIC—epilepsy syndrome	3.14e-06	4.96e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	3.13e-06	4.94e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	3.13e-06	4.94e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ABCB1—epilepsy syndrome	3.11e-06	4.9e-05	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	3.09e-06	4.87e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—ALB—epilepsy syndrome	3.07e-06	4.84e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CHRM3—epilepsy syndrome	3.06e-06	4.82e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	3.06e-06	4.82e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.03e-06	4.78e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PRKCB—epilepsy syndrome	3.03e-06	4.78e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	3.03e-06	4.77e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL6ST—epilepsy syndrome	3.02e-06	4.76e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—HMOX1—epilepsy syndrome	2.97e-06	4.68e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—AGT—epilepsy syndrome	2.96e-06	4.67e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—CAT—epilepsy syndrome	2.93e-06	4.62e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	2.92e-06	4.61e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GBE1—epilepsy syndrome	2.92e-06	4.61e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.92e-06	4.6e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—APOE—epilepsy syndrome	2.9e-06	4.57e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GPX1—epilepsy syndrome	2.89e-06	4.55e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CYP2D6—epilepsy syndrome	2.89e-06	4.55e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	2.88e-06	4.54e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	2.88e-06	4.54e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—POMC—epilepsy syndrome	2.86e-06	4.51e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	2.86e-06	4.51e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.86e-06	4.5e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	2.86e-06	4.5e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	2.86e-06	4.5e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ABCB1—epilepsy syndrome	2.85e-06	4.49e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	2.79e-06	4.39e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	2.77e-06	4.37e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—AGT—epilepsy syndrome	2.76e-06	4.36e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—POMC—epilepsy syndrome	2.76e-06	4.35e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.75e-06	4.34e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	2.75e-06	4.33e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ADRA2A—epilepsy syndrome	2.75e-06	4.33e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—BCHE—epilepsy syndrome	2.74e-06	4.31e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—APOE—epilepsy syndrome	2.71e-06	4.27e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCL2—epilepsy syndrome	2.7e-06	4.26e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PTGS2—epilepsy syndrome	2.69e-06	4.23e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.67e-06	4.21e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.66e-06	4.19e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GPX1—epilepsy syndrome	2.65e-06	4.18e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—SLC2A1—epilepsy syndrome	2.61e-06	4.11e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—ALB—epilepsy syndrome	2.61e-06	4.11e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.61e-06	4.11e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.61e-06	4.11e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.61e-06	4.11e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PLCB1—epilepsy syndrome	2.58e-06	4.07e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—TH—epilepsy syndrome	2.57e-06	4.06e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	2.55e-06	4.02e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—SRC—epilepsy syndrome	2.54e-06	4.01e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—AGT—epilepsy syndrome	2.53e-06	3.99e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.51e-06	3.95e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	2.5e-06	3.94e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—POMC—epilepsy syndrome	2.49e-06	3.93e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ABCG2—epilepsy syndrome	2.49e-06	3.93e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.49e-06	3.92e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.49e-06	3.92e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—APOE—epilepsy syndrome	2.48e-06	3.91e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	2.47e-06	3.9e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.46e-06	3.87e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—FGF2—epilepsy syndrome	2.44e-06	3.85e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	2.43e-06	3.83e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	2.43e-06	3.83e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	2.41e-06	3.8e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.38e-06	3.76e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	2.38e-06	3.75e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—BCHE—epilepsy syndrome	2.37e-06	3.74e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	2.35e-06	3.7e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.34e-06	3.68e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	2.33e-06	3.67e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—POMC—epilepsy syndrome	2.33e-06	3.67e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—AGT—epilepsy syndrome	2.33e-06	3.66e-05	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	2.3e-06	3.63e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.29e-06	3.61e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	2.29e-06	3.61e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PTGS2—epilepsy syndrome	2.28e-06	3.6e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—APOE—epilepsy syndrome	2.28e-06	3.59e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	2.28e-06	3.58e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—ALB—epilepsy syndrome	2.27e-06	3.58e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	2.27e-06	3.58e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—RELA—epilepsy syndrome	2.27e-06	3.57e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	2.26e-06	3.56e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	2.26e-06	3.55e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.24e-06	3.53e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.24e-06	3.53e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	2.24e-06	3.53e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	2.23e-06	3.52e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—TH—epilepsy syndrome	2.23e-06	3.51e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MTOR—epilepsy syndrome	2.22e-06	3.5e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.19e-06	3.46e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	2.18e-06	3.43e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	2.15e-06	3.38e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.15e-06	3.38e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—POMC—epilepsy syndrome	2.13e-06	3.36e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	2.13e-06	3.35e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—ALB—epilepsy syndrome	2.12e-06	3.34e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CAT—epilepsy syndrome	2.12e-06	3.34e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—BCHE—epilepsy syndrome	2.12e-06	3.33e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.08e-06	3.28e-05	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.08e-06	3.27e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	2.07e-06	3.27e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—BCHE—epilepsy syndrome	2.07e-06	3.25e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	2.06e-06	3.25e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CASP3—epilepsy syndrome	2.04e-06	3.22e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.04e-06	3.22e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	2.04e-06	3.21e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	2.02e-06	3.18e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	2e-06	3.15e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—TH—epilepsy syndrome	1.99e-06	3.14e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PTGS2—epilepsy syndrome	1.99e-06	3.13e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—JUN—epilepsy syndrome	1.99e-06	3.13e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	1.97e-06	3.1e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.96e-06	3.09e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—POMC—epilepsy syndrome	1.96e-06	3.08e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.95e-06	3.08e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PLCB1—epilepsy syndrome	1.95e-06	3.07e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.95e-06	3.07e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ALB—epilepsy syndrome	1.94e-06	3.06e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—TH—epilepsy syndrome	1.94e-06	3.06e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	1.94e-06	3.05e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MMP9—epilepsy syndrome	1.93e-06	3.04e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—BCHE—epilepsy syndrome	1.93e-06	3.04e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GPX1—epilepsy syndrome	1.92e-06	3.02e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.88e-06	2.97e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.88e-06	2.97e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	1.86e-06	2.93e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.86e-06	2.93e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PTGS2—epilepsy syndrome	1.86e-06	2.92e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	1.84e-06	2.9e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.84e-06	2.89e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CAT—epilepsy syndrome	1.84e-06	2.89e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—TH—epilepsy syndrome	1.83e-06	2.88e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	1.82e-06	2.87e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—TH—epilepsy syndrome	1.81e-06	2.86e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.79e-06	2.81e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	1.79e-06	2.81e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ALB—epilepsy syndrome	1.78e-06	2.81e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SRC—epilepsy syndrome	1.78e-06	2.81e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—VEGFA—epilepsy syndrome	1.74e-06	2.73e-05	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—AKT1—epilepsy syndrome	1.7e-06	2.68e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PTGS2—epilepsy syndrome	1.7e-06	2.68e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—AGT—epilepsy syndrome	1.68e-06	2.65e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	1.66e-06	2.62e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GPX1—epilepsy syndrome	1.66e-06	2.62e-05	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—AKT1—epilepsy syndrome	1.66e-06	2.61e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—APOE—epilepsy syndrome	1.65e-06	2.59e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CAT—epilepsy syndrome	1.64e-06	2.58e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—HMOX1—epilepsy syndrome	1.62e-06	2.55e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CAT—epilepsy syndrome	1.6e-06	2.52e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	1.59e-06	2.51e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—AKT1—epilepsy syndrome	1.58e-06	2.49e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	1.56e-06	2.46e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.54e-06	2.42e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.53e-06	2.41e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.51e-06	2.39e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.51e-06	2.37e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.5e-06	2.36e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CAT—epilepsy syndrome	1.49e-06	2.35e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.49e-06	2.34e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GPX1—epilepsy syndrome	1.48e-06	2.33e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.47e-06	2.31e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—AGT—epilepsy syndrome	1.46e-06	2.29e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	1.45e-06	2.29e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.45e-06	2.28e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—APOE—epilepsy syndrome	1.43e-06	2.25e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—POMC—epilepsy syndrome	1.41e-06	2.23e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.36e-06	2.15e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.35e-06	2.13e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—AKT1—epilepsy syndrome	1.35e-06	2.13e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.34e-06	2.12e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—AGT—epilepsy syndrome	1.3e-06	2.05e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ALB—epilepsy syndrome	1.29e-06	2.03e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.28e-06	2.01e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—APOE—epilepsy syndrome	1.27e-06	2.01e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.27e-06	2.01e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—AGT—epilepsy syndrome	1.27e-06	2e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—APOE—epilepsy syndrome	1.24e-06	1.96e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—POMC—epilepsy syndrome	1.23e-06	1.93e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.21e-06	1.91e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.2e-06	1.89e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—TH—epilepsy syndrome	1.2e-06	1.89e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.2e-06	1.88e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.18e-06	1.87e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.17e-06	1.85e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—APOE—epilepsy syndrome	1.16e-06	1.83e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—AKT1—epilepsy syndrome	1.15e-06	1.81e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	1.13e-06	1.78e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ALB—epilepsy syndrome	1.12e-06	1.76e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—AKT1—epilepsy syndrome	1.11e-06	1.74e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—POMC—epilepsy syndrome	1.09e-06	1.72e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—POMC—epilepsy syndrome	1.07e-06	1.68e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.01e-06	1.58e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—AKT1—epilepsy syndrome	1e-06	1.58e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	9.99e-07	1.57e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—POMC—epilepsy syndrome	9.97e-07	1.57e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ALB—epilepsy syndrome	9.97e-07	1.57e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CAT—epilepsy syndrome	9.85e-07	1.55e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	9.77e-07	1.54e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ALB—epilepsy syndrome	9.73e-07	1.53e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	9.59e-07	1.51e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—AKT1—epilepsy syndrome	9.33e-07	1.47e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ALB—epilepsy syndrome	9.17e-07	1.45e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ALB—epilepsy syndrome	9.09e-07	1.43e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GPX1—epilepsy syndrome	8.91e-07	1.4e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	8.72e-07	1.37e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—AKT1—epilepsy syndrome	8.55e-07	1.35e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PTGS2—epilepsy syndrome	8.51e-07	1.34e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	8.02e-07	1.26e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	7.95e-07	1.25e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—AKT1—epilepsy syndrome	7.85e-07	1.24e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—AGT—epilepsy syndrome	7.81e-07	1.23e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—APOE—epilepsy syndrome	7.66e-07	1.21e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—POMC—epilepsy syndrome	6.58e-07	1.04e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ALB—epilepsy syndrome	6e-07	9.45e-06	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—AKT1—epilepsy syndrome	5.67e-07	8.94e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	5.25e-07	8.27e-06	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—AKT1—epilepsy syndrome	4.91e-07	7.74e-06	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—AKT1—epilepsy syndrome	4.38e-07	6.91e-06	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—AKT1—epilepsy syndrome	4.28e-07	6.74e-06	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—AKT1—epilepsy syndrome	4.03e-07	6.35e-06	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—AKT1—epilepsy syndrome	4e-07	6.3e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.64e-07	4.15e-06	CbGpPWpGaD
